Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The current study aimed to explore the pharmacokinetics of temocillin in patients treated with haemodialysis and to demonstrated whether or not the pharmacodynamics target of a time above a MIC of 16 mg/L of more than 40 and 60 % of the dosing interval could be obtained with a dosing schedule of 1 gram/24 hours, 2 gram/48 hours and 3 gram/72 hours, all of these doses given after haemodialysis sessions only.
Critère d'inclusion
- Gram-Negative Bacterial Infections,Renal Failure Chronic Requiring Hemodialysis